66 related articles for article (PubMed ID: 32207885)
1. Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma.
Lu D; Yang J; Liu X; Feng S; Dong X; Shi X; Zhai J; Mai S; Jiang J; Wang Z; Wu H; Cai K
Cancer Med; 2020 May; 9(10):3455-3462. PubMed ID: 32207885
[TBL] [Abstract][Full Text] [Related]
2. Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.
Tsao MS; Marguet S; Le Teuff G; Lantuejoul S; Shepherd FA; Seymour L; Kratzke R; Graziano SL; Popper HH; Rosell R; Douillard JY; Le-Chevalier T; Pignon JP; Soria JC; Brambilla EM
J Clin Oncol; 2015 Oct; 33(30):3439-46. PubMed ID: 25918286
[TBL] [Abstract][Full Text] [Related]
3. Limited resection is comparable to lobectomy for tumor size ≤ 2 cm pulmonary invasive mucinous adenocarcinoma.
Lin W; Su H; Xie H; Xu L; Wang T; Wang L; Hu X; Zhao D; Zhu Y; Wang H; Jiang G; Xie D; Chen C;
World J Surg Oncol; 2024 Apr; 22(1):109. PubMed ID: 38664816
[TBL] [Abstract][Full Text] [Related]
4. Expansion of the Concept of Micropapillary Adenocarcinoma to Include a Newly Recognized Filigree Pattern as Well as the Classical Pattern Based on 1468 Stage I Lung Adenocarcinomas.
Emoto K; Eguchi T; Tan KS; Takahashi Y; Aly RG; Rekhtman N; Travis WD; Adusumilli PS
J Thorac Oncol; 2019 Nov; 14(11):1948-1961. PubMed ID: 31352072
[TBL] [Abstract][Full Text] [Related]
5. Wedge resection before lobectomy for patients with T1N0M0 non-small cell lung cancer: a propensity score matching analysis.
Zeng Y; Huang Y; Fu J; Xu K; Liang W; Cui F; Hao Z; Li X; Xing T; He J; Liu J
Ann Transl Med; 2022 May; 10(9):502. PubMed ID: 35928736
[TBL] [Abstract][Full Text] [Related]
6. [Advances in pathological study of micropapillary lung adenocarcinoma].
Zhao SN; Wu CY; Xie HK
Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1183-1188. PubMed ID: 37899333
[TBL] [Abstract][Full Text] [Related]
7. [Discrimination of lung cancer and adjacent normal tissues based on permittivity by optimized probabilistic neural network].
Yu H; Sun Y; Lu D; Cai K; Yu X
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Oct; 40(10):1500-1506. PubMed ID: 33118516
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of aprepitant as mono and combination therapy for the prevention of emetogenic chemotherapy-induced nausea and vomiting: post-marketing surveillance in China.
Yang Y; Yang N; Wu L; Ouyang Q; Fang J; Li J; Liao W; Cai K; Huang J; Li J; Zhang Y; Wang X; Zhang H; Xu N; Zhao Q; Hu X; Li W; Zhong W; Zhong D; Cheng G; Ye S; Zhong M; Wang D; Liu H; Zheng J; Liu X; Xu H; Zhang L
Chin Clin Oncol; 2020 Oct; 9(5):68. PubMed ID: 33161724
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA circNELL2 Acts as the Sponge of miR-127-5p to Promote Esophageal Squamous Cell Carcinoma Progression.
Xiong G; Diao D; Lu D; Liu X; Liu Z; Mai S; Feng S; Dong X; Cai K
Onco Targets Ther; 2020; 13():9245-9255. PubMed ID: 32982311
[TBL] [Abstract][Full Text] [Related]
10. Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database.
Zou L; Guo T; Ye L; Zhou Y; Chu L; Chu X; Ni J; Zhu Z; Yang X
Front Oncol; 2020; 10():572462. PubMed ID: 33324549
[TBL] [Abstract][Full Text] [Related]
11. Dual Primary Cancer Patients With Lung Cancer as a Second Primary Malignancy: A Population-Based Study.
Song C; Yu D; Wang Y; Wang Q; Guo Z; Huang J; Li S; Hu W
Front Oncol; 2020; 10():515606. PubMed ID: 33194578
[TBL] [Abstract][Full Text] [Related]
12. Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma.
Guo LH; Zhang MF; Zhang HL; Zhou JY; Cai XH; Long Y; Guo QS; Yang N; Zhao J; Xie ZH; Jiang B; Zhu Y; Fan Y; Xie CY; Hu Y; Yao Y; Jia J; Li XL; Cui JW; Sui XZ; Lin W; Cheng Y; Wang HJ; Wang CL; Zhao MF; Qiao GB; Peng LJ; Yang L; Chen GY; Cai KC; Xu XH; Zhang LM; Feng GS; Zhou JM; Wu GW; Dong XR; Wang LF; Zhang HM; Gao YJ; Jiang QY; Cang SD; Yang ZX; Song X; Liu XQ; Zhu B; Chen FX; Hu CH; Chen X; Wu YL; Zhou Q
Front Oncol; 2020; 10():1568. PubMed ID: 33042801
[No Abstract] [Full Text] [Related]
13. Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study.
Bai X; Wu DH; Ma SC; Wang J; Tang XR; Kang S; Fu QJ; Cao CH; Luo HS; Chen YH; Zhu HB; Yan HH; Wu YL; Dong ZY
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32606052
[TBL] [Abstract][Full Text] [Related]
14. Identifying optimal candidates for primary tumor resection among metastatic non-small cell lung cancer patients: a population-based predictive model.
Liang H; Liu Z; Huang J; Liu J; Wang W; Li J; Xiong S; Li C; Cheng B; Zhao Y; Cui F; He J; Liang W
Transl Lung Cancer Res; 2021 Jan; 10(1):279-291. PubMed ID: 33569312
[TBL] [Abstract][Full Text] [Related]
15. Machine Learning Models to Predict Primary Sites of Metastatic Cervical Carcinoma From Unknown Primary.
Lu D; Jiang J; Liu X; Wang H; Feng S; Shi X; Wang Z; Chen Z; Yan X; Wu H; Cai K
Front Genet; 2020; 11():614823. PubMed ID: 33408743
[TBL] [Abstract][Full Text] [Related]
16. Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States.
Sung H; Hyun N; Leach CR; Yabroff KR; Jemal A
JAMA; 2020 Dec; 324(24):2521-2535. PubMed ID: 33351041
[TBL] [Abstract][Full Text] [Related]
17. Sublobar Resection Versus Lobectomy for Early-Stage Pulmonary Carcinoid Tumors ≤3 cm in Size: A SEER Population-Based Study.
Xu S; Li X; Ren F; He J; Zhao S; Wang Y; Ren D; Zhu S; Lei X; Chen G; Chen J
Ann Surg; 2022 Dec; 276(6):e991-e999. PubMed ID: 33196487
[TBL] [Abstract][Full Text] [Related]
18. Overall Survival in Heart Disease-Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study.
Safi M; Kanesvaran R; Alradhi M; Al-Danakh A; Ping F; Al-Sabai N; Shan X; Liu J
Front Oncol; 2020; 10():572380. PubMed ID: 33194672
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database.
Campos-Balea B; de Castro Carpeño J; Massutí B; Vicente-Baz D; Pérez Parente D; Ruiz-Gracia P; Crama L; Cobo Dols M
Thorac Cancer; 2020 Nov; 11(11):3357-3364. PubMed ID: 32986309
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
Howlader N; Forjaz G; Mooradian MJ; Meza R; Kong CY; Cronin KA; Mariotto AB; Lowy DR; Feuer EJ
N Engl J Med; 2020 Aug; 383(7):640-649. PubMed ID: 32786189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
